Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 2Phase 4 2Phase 2 2Phase 1 1

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other 2Breast 1

Conditions

Obesity 2Polycystic Ovary Syndrome 1Overweight 1Breast Neoplasms 1

Interventions

Metformin 9Liraglutide 3Exercise 3semaglutide 2Tirzepatide 2Nutrition Assessment 2Docosahexaenoic Acids 2Diet 2sibutramine 1Ursodeoxycholic Acid 1Topiramate 1Solutions 1Resistance Training 1Propofol 1Progestins 1Nutrition Therapy 1Megestrol Acetate 1Medroxyprogesterone Acetate 1Magnetic Resonance Spectroscopy 1Injections 1Hysteroscopy 1Exenatide 1Estrogen Replacement Therapy 1Doxorubicin 1Cyproterone 1Cyclophosphamide 1Caloric Restriction 1(2-(1R)-1-cyclopropyl)ethyl-6-isopropyl-phenol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Obesity × Tirzepatide × Clear all
NCT07257484 2026-03-13

Tirzepatide's Role in Postmenopausal HR+ Breast Cancer Survivors

Weill Medical College of Cornell University

Phase 4 Not yet recruiting
30 enrolled
BreastOther

Breast Neoplasms, Obesity

NCT07326111 2026-01-08

PERIODS

University of Bonn

Phase 4 Recruiting
198 enrolled
Other

Obesity, Polycystic Ovary Syndrome, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon âš¡